PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded Entity, Seaport Therapeutics, ("Seaport") a ...
UBS Global Healthcare Conference Presenters: Bharatt Chowrira, Ph.D., J.D., Chief Executive Officer, and Eric Elenko, Ph.D., Co-founder and President Date: Wednesday, November 13, 2024 Time: 8:45 a.m.
Highlights,Seaport Therapeutics has successfully closed a $225 million Series B financing round, increasing total capital ...
PureTech Health (GB:PRTC) has released an update. PureTech Health, a clinical-stage biotherapeutics company, announced a transfer of shares by non-executive director John LaMattina to support ...
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is ...
The funding will support Seaport’s technology platform, which helps drugs be absorbed more efficiently through the lymphatic ...
Boston-based Seaport Therapeutics closed $225 million in new capital, bringing its total funding to $325 million.
Cambridge, MA, October 28, 2024 –Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence ...
The clinical-stage biopharmaceutical company, Seaport Therapeutics, which uses a unique drug delivery platform originally developed by Monash University, has announced the closing of an oversubscribed ...
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with ...